This federal contract award is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $14,071.18 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 30, 2024, with a completion date of December 2, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is part of that larger IDC contract with the DLA.
Generated 3/1/25, 9:46 AM